This is an observational study of patients with COVID-19 designed to specifically addressimportant clinical questions that remain incompletely answered for coronavirus disease2019.
Data from up to 5,000 adult patients in the US will be captured from eligible patients
enrolled following admission to the hospital. Participants will have de-identified
medical records collected from hospital admission to discharge, including but not limited
to critical care monitoring, details on mechanical ventilation, laboratory data, imaging
reports, medications, and all procedures. Diagnosis and patient management will follow
each hospital's standard of care and no specific treatments, procedures or laboratory
tests will be dictated by enrollment in TARGET-COVID-19.
Inclusion Criteria:
- Adults (age ≥18 years) who are or have been hospitalized and diagnosed with Severe
Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) infection.
- SARS-CoV-2 confirmed diagnosis (e.g. polymerase chain reaction [PCR] or other
clinically utilized test).
Exclusion Criteria:
N/A
University of Washington
Seattle, Washington, United States
Chuck Moser
984-234-0268
cmoser@targetpharmasolutions.com